Groundbreaking technology for early detection and analysis of cardiovascular disease

Purpose and goal

The aim of the project is to advance towards the commercialization of our AI-based technology for cardiovascular analysis through strategic partnerships, technical development, regulatory compliance and management of intellectual property rights. The goal is to complete an MVP through careful planning and collaboration with various stakeholders. The MVP will have been validated against users, customers and other stakeholders and will be able to be used for clinical trials for later commercialization.

Expected effects and result

- Partnership and market expansion through signed development agreements and business development for further opportunities. - Technical development with MVP for later commercialization. - Well-defined regulatory strategy and steps towards market approval, as well as workflow procedures that meet current regulations and standards. - Research and clinical progress, communicated results, plans for pilot study and clinical trial. - Progress in commercialization with signed commercial agreements and planning for launch.

Planned approach and implementation

The project is divided into four stages where each stage is approximately 6 months long. Each stage clearly takes us further towards the commercialization of our technology. Implementation will mostly be carried out by us at Beat Vascular Health ourselves, as we have the necessary competence to internally carry out most of the planned activities in the project. For the activities where we need additional competence, we will use external consultants and advisors who can add specialized knowledge and network where there is a need.